Literature DB >> 12957332

Effects of serotonin 5-HT(1/2) receptor agonists in a limited-access operant food intake paradigm in the rat.

J De Vry1, R Schreiber, A Daschke, K R Jentzsch.   

Abstract

Hypophagic effects of serotonergic drugs have mostly been investigated in free-feeding paradigms and are generally ascribed to drug-induced acceleration of satiety, or to behavioral disruption. The present study investigated the hypophagic effects of various 5-HT(1/2) receptor agonists in an operant paradigm. Because of its limited duration (10-min session) the procedure was considered to be relatively insensitive to satiety processes. The behavioral specificity of the hypophagic effect was assessed by additional testing of the compounds in a locomotor activity assay. Male Wistar rats, maintained at about 80% of their free-feeding weights, were trained to acquire stable operant responding in daily fixed ratio:10 food-reinforced sessions; after which they were tested once a week with a 5-HT receptor agonist. Each compound dose-dependently suppressed the number of earned pellets after i.p. administration: DOI (5-HT(2A/2C) receptor agonist; ED(50): 0.36 mg/kg), TFMPP (5-HT(1B/2C/2A); 0.37 mg/kg), m-CPP (5-HT(2C/1B/2A); 0.54 mg/kg), ORG 37684 (5-HT(2C/2A); 0.85 mg/kg), CP-94,253 (5-HT(1B); 2.09 mg/kg), BW 723C86 (5-HT(2B); 6.26 mg/kg) and ipsapirone (5-HT(1A); 10.17 mg/kg). When tested at the dose equivalent to the ED(50) value in the operant paradigm, only ORG 37684 and DOI weakly suppressed activity counts in a locomotor activity assay; suggesting that the inhibition of operant food intake obtained with the other compounds at these doses is not a direct consequence of unconditioned motor effects. It is suggested that the hypophagic effect induced by relatively low doses of CP-94,253, TFMPP and m-CPP, and by moderate doses of ipsapirone and BW 723C86, is partly due to a drug-induced suppression of appetite. Although the exact contribution of the diverse 5-HT(1/2) receptor subtypes to appetite control remains to be studied in more detail, it is hypothesized that activation of 5-HT(1B) and/or 5-HT(2C) receptors attenuates appetite.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957332     DOI: 10.1016/s0924-977x(03)00014-2

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  6 in total

1.  Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI.

Authors:  Katelyn A Carr; Henry Lin; Kelly D Fletcher; Lara Sucheston; Prashant K Singh; Robbert J Salis; Richard W Erbe; Myles S Faith; David B Allison; Eric Stice; Leonard H Epstein
Journal:  Behav Neurosci       Date:  2013-04-01       Impact factor: 1.912

2.  The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions.

Authors:  Clare M Mathes; Jillian R Gregson; Alan C Spector
Journal:  Chem Senses       Date:  2012-12-19       Impact factor: 3.160

3.  5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and running.

Authors:  Eric W Fish; Sara D McKenzie-Quirk; Makoto Bannai; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-12-11       Impact factor: 4.530

4.  Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.

Authors:  G L Dalton; M D Lee; G A Kennett; C T Dourish; P G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

5.  In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay.

Authors:  Ellen A Walker; Edward K Brown; Steven N Sterious
Journal:  Psychopharmacology (Berl)       Date:  2007-04-01       Impact factor: 4.415

6.  The Interpeduncular-Ventral Hippocampus Pathway Mediates Active Stress Coping and Natural Reward.

Authors:  Yasmine Sherafat; Malia Bautista; J P Fowler; Edison Chen; Amina Ahmed; Christie D Fowler
Journal:  eNeuro       Date:  2020-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.